Glenmark Pharmaceuticals informs about press release

24 Feb 2016 Evaluate

Glenmark Pharmaceuticals has informed about a press release dated February 24, 2016, titled ‘Glenmark Pharmaceuticals receives ANDA approval for Norgestimate and Ethinyl Estradiol Tablets USP, 0.18 mg/0.025 mg, 0.215 mg/0.025 mg, and 0.25 mg/0.025 mg’.

The above information is a part of company’s filings submitted to BSE.

Glenmark Pharma Share Price

1962.50 -3.55 (-0.18%)
17-Dec-2025 10:10 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1778.65
Dr. Reddys Lab 1271.95
Cipla 1496.95
Zydus Lifesciences 917.95
Lupin 2118.30
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×